{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:44Z","timestamp":1786120364929,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/jcp.0b013e31822c0a68","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:58:34Z","timestamp":1317743914000},"page":"569-576","source":"Crossref","is-referenced-by-count":66,"title":["Symptomatic and Functional Improvement in Employed Depressed Patients"],"prefix":"10.1097","volume":"31","author":[{"given":"Boadie W.","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujana","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Lubaczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Focht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Guico-Pabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1176\/appi.ajp.157.8.1274","article-title":"Health and disability costs of depressive illness in a major U.S. corporation.","volume":"157","author":"Druss","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","article-title":"The economic burden of depression in the United States: how did it change between 1990 and 2000?","volume":"64","author":"Greenberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1176\/ajp.2006.163.9.1561","article-title":"Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.","volume":"163","author":"Kessler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(98)00191-8","article-title":"Depression in a primary care clinic: the prevalence and impact of an unrecognized disorder.","volume":"55","author":"McQuaid","year":"1999","journal-title":"J Affect Disord"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.1992.01820100005001","article-title":"Treatments of depression and the functional capacity to work.","volume":"49","author":"Mintz","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.genhosppsych.2007.06.002","article-title":"Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability.","volume":"29","author":"Egede","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/00005650-200412000-00007","article-title":"The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial.","volume":"42","author":"Rost","year":"2004","journal-title":"Med Care"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1001\/jama.289.23.3135","article-title":"Cost of lost productive work time among US workers with depression.","volume":"289","author":"Stewart","year":"2003","journal-title":"JAMA"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.24095\/hpcdp.28.3.01","article-title":"The effect of bipolar I disorder and major depressive disorder on workforce function.","volume":"28","author":"McIntyre","year":"2008","journal-title":"Chronic Dis Can"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1176\/appi.ps.55.12.1371","article-title":"Unemployment, job retention, and productivity loss among employees with depression.","volume":"55","author":"Lerner","year":"2004","journal-title":"Psychiatr Serv"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.","volume":"48","author":"Frank","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.57.4.375","article-title":"Psychosocial disability during the long-term course of unipolar major depressive disorder.","volume":"57","author":"Judd","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.psychres.2010.02.008","article-title":"Correlation between patient and clinician assessments of depression severity in the PREVENT study.","volume":"177","author":"Dunlop","year":"2010","journal-title":"Psychiatry Res"},{"key":"R15-4-20210128","first-page":"81","article-title":"Work loss and depression. Impact of fluoxetine in French.","volume":"48","author":"Souetre","year":"1993","journal-title":"Therapie"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1007397913193","article-title":"Predicting factors for absenteeism in patients with major depressive disorders.","volume":"13","author":"Souetre","year":"1997","journal-title":"Eur J Epidemiol"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice.","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.106.103382","article-title":"Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor.","volume":"318","author":"Deecher","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 20","key":"R20-4-20210128","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument.","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"R26-4-20210128","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity.","volume":"26","author":"McGahuey","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/157340010790596526","article-title":"Response to treatment with placebo, medication or psychotherapy in severe non-psychotic major depressive disorder.","volume":"6","author":"Dunlop","year":"2010","journal-title":"Curr Psychiatry Rev"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archpsyc.62.4.409","article-title":"Cognitive therapy vs medications in the treatment of moderate to severe depression.","volume":"62","author":"DeRubeis","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1092852900020204","article-title":"An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.","volume":"14","author":"Clayton","year":"2009","journal-title":"CNS Spectr"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1185\/03007990903408678","article-title":"Clinical utility of desvenlafaxine 50 mg\/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.","volume":"26","author":"Reddy","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4088\/JCP.09m05133blu","article-title":"Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.","volume":"70","author":"Soares","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing.","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4088\/JCP.08r04516blu","article-title":"Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.","volume":"71","author":"Sinyor","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"suppl 433","key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0447.2007.00970.x","article-title":"Treatment response in melancholia.","volume":"115","author":"Brown","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1037\/h0100089","article-title":"A qualitative and quantitative review of behavioral activation treatment of major depressive disorder.","volume":"7","author":"Spates","year":"2006","journal-title":"Behav Anal Today"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/JCP.0b013e3181d52dea","article-title":"Antidepressants work, sort of-our system of care does not.","volume":"30","author":"Pies","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jpsychires.2004.06.005","article-title":"Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.","volume":"39","author":"Khan","year":"2005","journal-title":"J Psychiatr Res"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis.","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201110000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:03Z","timestamp":1786048023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201110000-00004"}},"subtitle":["A Double-Blind Clinical Trial of Desvenlafaxine Versus Placebo"],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31822c0a68","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}